Colgate-Palmolive (NYSE:CL) PT Raised to $104.00

Colgate-Palmolive (NYSE:CLFree Report) had its price objective upped by Deutsche Bank Aktiengesellschaft from $98.00 to $104.00 in a research note published on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock.

Other equities research analysts have also issued research reports about the company. Wells Fargo & Company increased their target price on Colgate-Palmolive from $92.00 to $97.00 and gave the company an equal weight rating in a research note on Wednesday, July 10th. Evercore ISI lifted their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the company an outperform rating in a research note on Monday, April 8th. Stifel Nicolaus upped their target price on shares of Colgate-Palmolive from $94.00 to $95.00 and gave the company a buy rating in a research note on Monday, April 29th. BNP Paribas assumed coverage on shares of Colgate-Palmolive in a research note on Monday, June 24th. They set an outperform rating and a $109.00 price target on the stock. Finally, Argus boosted their price objective on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the stock a buy rating in a report on Wednesday, May 15th. Three analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of Moderate Buy and a consensus target price of $96.94.

Check Out Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Stock Down 0.4 %

CL opened at $98.09 on Wednesday. The company has a market cap of $80.48 billion, a PE ratio of 31.04, a price-to-earnings-growth ratio of 3.66 and a beta of 0.39. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.70 and a current ratio of 1.06. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $99.63. The firm has a 50 day moving average price of $95.53 and a 200 day moving average price of $89.47.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its earnings results on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The business had revenue of $5.07 billion for the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter last year, the firm posted $0.73 EPS. The business’s revenue for the quarter was up 6.2% compared to the same quarter last year. Sell-side analysts expect that Colgate-Palmolive will post 3.54 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.04%. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%.

Insider Activity

In related news, insider Sally Massey sold 12,226 shares of the stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the sale, the insider now owns 13,924 shares in the company, valued at $1,309,691.44. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the transaction, the insider now directly owns 13,924 shares in the company, valued at approximately $1,309,691.44. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the sale, the insider now owns 3,181 shares in the company, valued at $297,328.07. The disclosure for this sale can be found here. Company insiders own 0.34% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in shares of Colgate-Palmolive by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 79,894,344 shares of the company’s stock worth $6,368,378,000 after buying an additional 416,853 shares during the period. Price T Rowe Associates Inc. MD increased its holdings in shares of Colgate-Palmolive by 27.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock valued at $3,698,096,000 after purchasing an additional 8,933,912 shares during the period. Norges Bank acquired a new position in shares of Colgate-Palmolive during the fourth quarter valued at $731,843,000. GUARDCAP ASSET MANAGEMENT Ltd increased its holdings in shares of Colgate-Palmolive by 4.1% during the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,987,454 shares of the company’s stock valued at $629,220,000 after purchasing an additional 278,150 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Colgate-Palmolive by 1.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,426,430 shares of the company’s stock valued at $352,824,000 after purchasing an additional 77,679 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.